PRLD (STOCKS)
Prelude Therapeutics Incorporated
$4.460000
-0.030000 (-0.67%)
Prev close: $4.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Krishna Vaddi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $356.01M
- Employees
- 131
- P/E (TTM)
- -4.22
- P/B (TTM)
- 4.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $16.72M |
| Operating Expenses | $100.86M |
| Research and Development | $79.09M |
| Other Operating Expenses | $21.77M |
| Operating Income/Loss | -$84.14M |
| Income/Loss From Continuing Operations After Tax | -$77.80M |
| Income/Loss From Continuing Operations Before Tax | -$51.57M |
| Net Income/Loss | -$77.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$77.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 235,564,398 |
| Diluted Average Shares | 235,564,398 |
| Assets | $119.64M |
| Current Assets | $84.59M |
| Noncurrent Assets | $35.05M |
| Fixed Assets | $4.72M |
| Other Non-current Assets | $30.33M |
| Liabilities | $59.46M |
| Current Liabilities | $41.72M |
| Accounts Payable | $2.07M |
| Wages | $2.53M |
| Other Current Liabilities | $37.12M |
| Noncurrent Liabilities | $17.74M |
| Equity | $60.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $60.18M |
| Liabilities And Equity | $119.64M |
| Net Cash Flow From Operating Activities | -$43.76M |
| Net Cash Flow From Operating Activities, Continuing | -$43.76M |
| Net Cash Flow From Investing Activities | -$228.00K |
| Net Cash Flow From Investing Activities, Continuing | -$228.00K |
| Net Cash Flow From Financing Activities | $24.66M |
| Net Cash Flow From Financing Activities, Continuing | $24.66M |
| Net Cash Flow | -$19.32M |
| Net Cash Flow, Continuing | -$19.32M |
| Comprehensive Income/Loss | -$77.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$77.85M |
| Other Comprehensive Income/Loss | -$19.77M |